These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 90449)

  • 1. The expression of a human B-lymphocyte antigen and surface membrane immunoglobulin by lymphoid cells from patients with lymphocytic lymphoma, multiple myeloma and benign monoclonal gammapathy.
    Turesson I; Berntorp E; Zettervall O
    Acta Med Scand; 1979; 206(1-2):37-44. PubMed ID: 90449
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphocyte surface markers in lymphoproliferative disorders.
    Aiuti F; Lacava V; Fiorilli M; Ciarla MV
    Acta Haematol; 1973; 50(5):275-83. PubMed ID: 4202631
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution of immunoglobulin-containing cells in bone marrow and lymphoid tissues in patients with monoclonal gammapathy.
    Turesson I
    Acta Med Scand; 1978; 203(4):247-55. PubMed ID: 347889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating and bone marrow immunoglobulin-secreting cells in patients with monoclonal gammopathies. A simple and reliable marker for a B-cell function.
    Dammacco F; Vacca A; Altomare E; Campobasso N
    Semin Hematol; 1985 Apr; 22(2):115-20. PubMed ID: 3890189
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoclonal lymphoid cell surface immunoglobulins with tumor-specific determinants in lymphosarcoma.
    Schedel I; Fink PC; Bodenberger M; Deicher H
    Clin Immunol Immunopathol; 1976 Jan; 5(1):74-83. PubMed ID: 57020
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of antiserum against myeloma cells.
    Cawley LP; Goodwin WL; Minard BJ
    Cancer Res; 1973 Jan; 33(1):17-22. PubMed ID: 4629871
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immune-cytological studies on the distribution pattern of Ig determinants in myeloma patients. Thoughts on a class specific restriction to B-lymphocytes].
    Asamer H; Baumgartl R; Braunsteiner H
    Acta Haematol; 1973; 49(2):80-8. PubMed ID: 4197461
    [No Abstract]   [Full Text] [Related]  

  • 8. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
    Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
    Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-lymphoproliferative disorders: a proposed unified pathogenetic pathway.
    Ezdinli EZ; Nanus DM
    Hematol Oncol; 1983; 1(4):297-319. PubMed ID: 6429025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The monoclonal nature of lymphatic leukemia.
    Seligmann M; Preud'homme JL; Brouet JC
    Birth Defects Orig Artic Ser; 1975; 11(1):163-70. PubMed ID: 50095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Subsets of T cells in myeloma, macroglobulinemia and benign monoclonal gammopathy: analysis of surface markers defined by monoclonal antibodies and the effect on Ig-synthesis by B cells].
    Okagawa K; Iguchi K; Iishi Y; Kosaka M
    Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1205-13. PubMed ID: 3934898
    [No Abstract]   [Full Text] [Related]  

  • 12. Idiotypic lymphocytes in human monoclonal gammopathies.
    Boccadoro M; Van Acker A; Pileri A; Urbain J
    Ann Immunol (Paris); 1981; 132C(1):9-19. PubMed ID: 6973315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective monocyte chemotactic responsiveness in patients with multiple myeloma and benign monoclonal gammapathy.
    Dammacco F; Miglietta A; Ventura MT; Bonomo L
    Clin Exp Immunol; 1982 Feb; 47(2):481-6. PubMed ID: 7075030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of B cell neoplasia.
    Deegan MJ
    Henry Ford Hosp Med J; 1984; 32(1):20-30. PubMed ID: 6204956
    [No Abstract]   [Full Text] [Related]  

  • 15. Malignant lymphomas of B-cell type.
    Stein H; Lennert K; Parwaresch MR
    Lancet; 1972 Oct; 2(7782):855-7. PubMed ID: 4116558
    [No Abstract]   [Full Text] [Related]  

  • 16. Idiotypic immunoglobulin structures on blood lymphocytes in human plasma cell myeloma.
    Holm G; Mellstedt H; Pettersson D; Biberfeld R
    Immunol Rev; 1977; 34():139-64. PubMed ID: 66782
    [No Abstract]   [Full Text] [Related]  

  • 17. B and T cell markers of bone marrow and peripheral blood lymphoid cells in patients with paraproteinaemia.
    Husz S; Krizsa F; Dobozy A; Hunyadi J; Simon N
    Acta Haematol; 1977; 57(6):321-30. PubMed ID: 70148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin receptors on human leukocytes. IV. Differences between bone marrow and blood cells in multiple myeloma and chronic lymphocytic leukemia: effects of therapy.
    Abdou NL; Abdou NI
    J Lab Clin Med; 1973 Oct; 82(4):611-8. PubMed ID: 4543193
    [No Abstract]   [Full Text] [Related]  

  • 19. Surface-bound immunoglobulin on B-lymphocytes, evidence for allelic exclusion.
    Natvig JB; Froland SS
    Ann Immunol (Paris); 1974 Jan; 125C(1-2):281-6. PubMed ID: 4142558
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of immunoglobulin synthesis by lymphocytes in multiple myeloma and benign monoclonal gammopathy.
    Takeshita A
    Nihon Ketsueki Gakkai Zasshi; 1986 Sep; 49(6):1195-205. PubMed ID: 3492847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.